首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of market access health policy

缩写:

ISSN:2001-6689

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引352
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Susana Murteira,Aurélie Millier,Zied Ghezaiel et al. Susana Murteira et al.
Background: Repurposing has become a mainstream strategy in drug development, but it faces multiple challenges, amongst them the increasing and ever changing regulatory framework. This is the second study of a series of t...
Mondher Toumi,Guy Jadot Mondher Toumi
Background: Recently, collaboration between regulators and payers was set up and was mainly focused on evidence generation along product clinical development. However, neither the regulatory path nor the new active substa...
Duccio Urbinati,Cécile Rémuzat,Åsa Kornfeld et al. Duccio Urbinati et al.
Background and objectives: With constant incentives for healthcare payers to contain their pharmaceutical budgets, forecasting has become critically important. Some countries have, for instance, developed pharmaceutical h...
Mart Oude Egbrink,Maarten IJzerman Mart Oude Egbrink
Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do h...
Jean-Louis Kraus Jean-Louis Kraus
At the present time, developed countries are making a huge financial effort to support neuroscience research programs, particularly in the fields of advanced research and treatment of brain diseases and mental disorders. A part of this fina...
Anuj Kumar,Karthaveerya Juluru,Phani Kishore Thimmaraju et al. Anuj Kumar et al.
This article intends to consolidate the concepts of pharmaceutical market access and highlight its growing importance in emerging markets. Market access has gained considerable attention worldwide as countries try to contain their escalatin...
Susana Murteira,Aurélie Millier,Mondher Toumi Susana Murteira
Background: Drug repurposing is a group of development strategies employed in order to overcome some of the hurdles innate to drug research and development. Drug repurposing includes drug repositioning, reformulation and ...
Dávid Dankó Dávid Dankó
Because of significant differences in institutional contexts, health technology assessment (HTA) systems that are in place in core pharmaceutical markets may not be suitable, fully or in part, for middle-income countries (MICs) and for othe...
Siobhan Bourke,Richéal Maria Burns,Caroline Gaynor Siobhan Bourke
Background: Prostate cancer (PCa), the most commonly diagnosed cancer among men in the United States and Europe, is an escalating resource allocation issue across healthcare systems in the Western world. The impact of ske...
Cécile Rémuzat,Duccio Urbinati,Åsa Kornfeld et al. Cécile Rémuzat et al.
Background and objective: With constant incentives for healthcare payers to contain their pharmaceutical budgets, modelling policy decision impact became critical. The objective of this project was to test the impact of v...